Emyria (ASX:EMD)
ASX announcement history & article coverage
Transparent by design.
Announcments by Emyria (ASX:EMD) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Appendix 4E & Annual Financial Report Year End 30 June 2026
2026 Annual General Meeting - Key Dates
Emyria Unlocks Treatment Capacity
Emyria resolves prescriber bottleneck and recruits therapists to expand Q4 dosing capacity
Notification of cessation of securities - EMD
Change of Registered Office and Principal Place of Business
June 2026 Quarterly Activities Report and Appendix 4C
Emyria expands national clinic network, reports strong revenue growth and positive early depression treatment outcomes
June 2026 Quarterly Investor Webinar
Techknow Invest Roadshow Company Presentation
EMD to Present at Addressing the Mental Health Crisis Event
Emyria to Present at Upcoming Investor and Industry Events
Emyria Depression Program Shows Positive Results
Emyria reports encouraging early results in treatment-resistant depression program
Emyria Confirms NSW Workforce Ahead of Clinic Opening
Emyria trains NSW clinicians ahead of Sydney Empax clinic opening in Q3 2026
Emyria Company Update - Video Presentation
Emyria Company Update Presentation
Emyria updates on clinic progress, market opportunity, and funding in psychedelic-assisted therapy
Notification of cessation of securities - EMD